Medication‐related osteonecrosis of the jaw and non-antiresorptive medications

osteonecrosis

This review of the association between non-antiresorptive medications and medication‐related osteonecrosis of the jaw (MRONJ) included 70 studies. A majority of the studies (77%) were case series and the quantity and quality of the evidence is low so the findings should be interpreted cautiously.

[read the full story...]

MRONJ: Medication-related osteonecrosis of the jaw management strategies

Stage_2_MRONJ

15 systematic reviews were included in this review of teh treament and management of medication-related osteonecrosis of the jaw (MRONJ). The reviews only identified weak evidence to support treatment protocols for MRONJ so high quality well reported RCTs are needed.

[read the full story...]

Medication-related osteonecrosis of the jaw (MRONJ): treatment and prevention

bisphosphonate

This Cochrane review of interventions for the prevention and treatment of medication-related osteonecrosis of the jaw (MRONJ) identified 5 trials. Three were related to prevention and two to treatment providing limited evidence to support interventions. More high quality studies are needed.

[read the full story...]